Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$62.17 - $97.62 $1.46 Million - $2.3 Million
-23,560 Reduced 29.26%
56,949 $5.56 Million
Q4 2022

Feb 14, 2023

BUY
$60.21 - $77.74 $1.38 Million - $1.78 Million
22,855 Added 39.64%
80,509 $5 Million
Q3 2022

Nov 14, 2022

SELL
$72.92 - $99.73 $437,447 - $598,280
-5,999 Reduced 9.42%
57,654 $4.2 Million
Q2 2022

Aug 15, 2022

BUY
$84.23 - $147.57 $1.9 Million - $3.32 Million
22,504 Added 54.69%
63,653 $6.02 Million
Q1 2022

May 16, 2022

BUY
$122.89 - $171.74 $1.64 Million - $2.29 Million
13,306 Added 47.79%
41,149 $5.69 Million
Q4 2021

Feb 14, 2022

BUY
$156.0 - $265.78 $1.29 Million - $2.19 Million
8,238 Added 42.02%
27,843 $5.08 Million
Q3 2021

Nov 15, 2021

BUY
$228.69 - $274.2 $4.48 Million - $5.38 Million
19,605 New
19,605 $5.07 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.